Growth Metrics

Beneficient (BENF) EBIT (2021 - 2025)

Beneficient's EBIT history spans 5 years, with the latest figure at -$13.0 million for Q3 2025.

  • For Q3 2025, EBIT rose 5.46% year-over-year to -$13.0 million; the TTM value through Sep 2025 reached -$128.8 million, up 88.07%, while the annual FY2024 figure was -$2.6 billion, 946.14% down from the prior year.
  • EBIT for Q3 2025 was -$13.0 million at Beneficient, up from -$92.6 million in the prior quarter.
  • Across five years, EBIT topped out at $44.3 million in Q2 2024 and bottomed at -$1.2 billion in Q2 2023.
  • The 5-year median for EBIT is -$73.0 million (2022), against an average of -$228.0 million.
  • The largest annual shift saw EBIT tumbled 1244.92% in 2023 before it surged 103.84% in 2024.
  • A 5-year view of EBIT shows it stood at -$23.2 million in 2021, then crashed by 214.15% to -$73.0 million in 2022, then tumbled by 1154.73% to -$916.0 million in 2023, then skyrocketed by 98.96% to -$9.5 million in 2024, then plummeted by 36.3% to -$13.0 million in 2025.
  • Per Business Quant, the three most recent readings for BENF's EBIT are -$13.0 million (Q3 2025), -$92.6 million (Q2 2025), and -$9.5 million (Q4 2024).